Cingulate Inc. Common Stock (CING) is a publicly traded Healthcare sector company. As of September 17, 2026, CING trades at $5.12 with a market cap of $74.31M and a P/E ratio of -1.43. CING moved +1.38% today. Year to date, CING is +17.28%; over the trailing twelve months it is +29.52%. Its 52-week range spans $3.16 to $11.89. Analyst consensus is strong buy with an average price target of $20.33. Rallies surfaces CING's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CING financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. CING recently traded at $5.12. Market cap is $74.31M. P/E ratio is -1.43. Revenue is $-1.79M.
| Metric | Value |
|---|---|
| Price | $5.12 |
| Market Cap | $74.31M |
| P/E Ratio | -1.43 |
| EPS | $-3.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $11.89 |
| 52-Week Low | $3.16 |
| Volume | 15.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $-1.79M |
| Net Income | $-28.80M |
| Gross Margin | 0.00% |
3 analysts cover CING: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.33.